saascode
healthcare & clinical·run 318 · Aug 2026

Preverdict

A point-of-care prior-authorization evidence assistant that presents current payer-rule candidates, missing documentation and non-clinical coverage questions for staff review.

Genesis score6.60/10
Make Preverdict real.0/500
500 more votes and Preverdict is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The case

Small clinical practices may discover prior-authorization requirements only after the patient leaves, creating delays and repeated documentation work. Preverdict proposes an embedded, point-of-care evidence checklist at order entry. The supplied research confirms SMART-on-FHIR launch patterns, an API with payer-rule, gap-analysis, formulary and approval-rate capabilities, and open-source clinical integration tooling. It also corrects a key premise: the named health-data orchestration product is not a prior-authorization latency tool, and the claimed sub-ten-second authorization result could not be verified. The product must not inherit that speed claim.

A payer rule or historical approval rate is not a verdict for this patient. Coverage depends on member eligibility, benefit, plan version, network, diagnosis, procedure, prior treatment, documentation, site of care and payer review. Rules can be stale or incomplete, and commercial and regulated payer segments may differ. A covered alternative is not necessarily clinically appropriate; only the treating clinician and patient can decide care. The tool should not change an order, delay urgent care or expose protected health information beyond the authorized context.

Patient identity, clinician identity, launch authorization, encounter, intended order, clinical rationale, payer and plan hypothesis, eligibility response, rule source, rule version, evidence-gap candidate, staff finding, clinician decision, authorization request, payer acknowledgment, pending status, approval, denial, appeal, alternative-coverage observation, clinical choice and outcome remain separate. Historical approvals are observations, not ground truth for prediction. The first release should replay one low-risk medical-benefit workflow with synthetic or authorized data and output questions and citations—not approval probability or treatment alternatives.

Who pays — and why

A prior-authorization, revenue-cycle or clinical-operations leader at a small practice that wants missing-documentation questions surfaced during the encounter without automating clinical or payer decisions.

What it unlocks
An encounter-scoped authorization layer preserving patient and clinician identity, launch context, purpose, minimum necessary fields, consent where applicable, access and audit history
A versioned payer evidence registry linking plan hypothesis, eligibility, rule source, effective date, procedure context, required documents, known omissions and staff corrections
A prior-authorization lifecycle separating gap candidate, staff finding, clinician rationale, request, payer acknowledgment, status, determination, appeal and later outcome
How Genesis scored it
6.60across seven criteria
tension 6temporal 8blindspot 6buyer 6leverage 6convergence 5why-not 8
8
Temporal window

Confirmed policy and interoperability changes plus available gap-analysis capabilities create a current validation window.

8
Why nobody did it

Plan-specific rules, clinical context, protected data and payer-state reconciliation explain why a fast rule lookup does not produce a verdict.

5
Convergence

Two cross-references, one inbound and several direct connections support internal coherence without an external convergence cluster.

Why it scored well

The input names a costly clinical workflow, confirms embedded launch and gap-analysis primitives and proposes a useful shift from back-office discovery to point-of-care evidence preparation.

What's holding it back

The speed precedent is invalid, payer rules and outcomes are not approval ground truth, the buyer and integration burden remain incomplete, and covered alternatives risk clinical overreach.

Signals detected4 sources crossed
SignalSupplied capability research

SignalSupplied capability research

SignalSupplied competitor correction

SignalSupplied competitor research

Direction briefpreverdict.md
preverdict.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.